MGI and Imperial College will jointly operate a CEC designed to provide European customers with first-hand experience with various automation and sequencing instruments.
MGI Tech, a provider of tools and technology for the life sciences sector, announced the opening of an overseas Customer Experience Center (CEC) in London on Nov. 3, 2022. The second such suite in Europe, the new London site is designed to provide local customers and partners first-hand experience with MGI’s various instruments. The company’s other European site, located in Riga, Latvia, opened its doors in late October.
According to a company press release, the center will be operated by partners from the BRC Genomics Facility at Imperial College, London. In addition to various MGI automation systems, the facility will host the United Kingdom’s first DNBSEQ-G400 sequencer, which is designed to facilitate metagenomic analysis, spatial transcriptomics, microbiome, spatiotemporal omics, whole genome sequencing, whole exome sequencing, RNA sequencing, and more.
“Our new CEC will allow easier access to our cutting-edge technology locally. It will also serve as a hub for visitors to come in and experience MGI’s platforms for hands-on workflow, for our field application scientists to perform experiments for demo application, validation, and field testing, as well as for internal and external trainings,” said Duncan Yu, President, MGI, in the release. “We at MGI are proud to support researchers and partners in the region to develop content with our automation and sequencing platforms.”
“The new CEC is an important link to the local research and diagnostic community, enabling new genomic discoveries and medical advances,” said Yong Hou, General Manager, MGI Europe and Africa, in the release. “It has been wonderful to witness how MGI’s developments are transforming research and diagnostics, and our technology* will continue to empower local customers and partners to serve a greater purpose.”
Source: MGI
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.